4//SEC Filing
HOGUE GERALD L. 4
Accession 0001104659-23-036164
CIK 0001811764other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 8:09 PM ET
Size
7.1 KB
Accession
0001104659-23-036164
Insider Transaction Report
Form 4
HOGUE GERALD L.
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-03-21−17,936→ 17,936 totalExercise: $6.97Exp: 2026-12-01→ Common Stock (17,936 underlying) - Exercise/Conversion
Common Stock
2023-03-21$6.97/sh+17,936$125,014→ 21,596 total
Footnotes (1)
- [F1]As previously reported in a Form 4 filed with the Securities and Exchange Commission on June 30, 2021, the reporting person received an option to purchase 35,872 shares of the issuer's common stock (the "Option"). The Option vested 25% on December 1, 2021 and 25% on December 1, 2022, and will vest 25% on December 1, 2023 and 25% on December 1, 2024.
Documents
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeother
Related Parties
1- filerCIK 0001868738
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 8:09 PM ET
- Size
- 7.1 KB